700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02397

Synthetic patientMETA-24 · Day 107 · 65–74 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
5%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S20
  2. Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 10.

Primary contributors, last 14 days
  • GI instability-10
  • Nutritional resilience+8
  • Inflammatory activity-5

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    70 min
    stable · +2.2 vs previous 14 d
    Sleep duration
    Wearable
    6.7 h
    stable · +0.3 vs previous 14 d
    Energy level
    Daily log
    7.2/10
    improving · +0.6 vs previous 14 d
    Steps
    Wearable
    7,958
    improving · +355 vs previous 14 d
    GI burden
    Companion
    10.3/100
    improving · -11.1 vs previous 14 d
    Adherence
    Companion
    92.9 %
    stable · -1.7 vs previous 14 d
    Sleep quality
    Wearable
    51/100
    improving · +7.7 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    131 mg/dL
    stable · -4.4 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 91 from the failing basin, 10 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +11.4
    • Butyrate producers intact
      hidden · steering +7.5
    • Alcohol (supports)
      perturbation · steering +5.6
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -6.5 next day
    • Alcohol
      supporter · GI -3.6 next day
    Main detractors to watch
    • Rapid metabolizer
      hidden · steering -8
    • Low microbial diversity
      hidden · steering -7.7
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • Ultra-processed food
      perturbation · steering -6.5
    • Ultra-processed food
      detractor · GI +5.4 next day
    • Simple carbohydrates
      detractor · GI +3.2 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -6.5supporter · 95%
    • Ultra-processed food
      +5.4detractor · 95%
    • Alcohol
      -3.6supporter · 66%
    • Simple carbohydrates
      +3.2detractor · 64%
    • Histamine load
      -1.7no signal · 30%
    • Caffeine
      +1.4no signal · 23%
    • Insoluble fibre
      -1.1no signal · 20%
    • Dietary fat load
      -0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Inflammatory signalling ↓20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Rapid metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    Microbiome
    Shannon diversity 2.8 · butyrate capacity 57/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    51 ms
    Sleep
    6.7 h
    Steps
    8,254
    Resting HR
    72 bpm
    Daily log: GI score 10, nutritional resilience 70, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0212745%S11SC-12improved73
    P-0263045%S17NP-02improved76
    P-0266744%S08HY-01improved77
    P-0206841%S14NP-02improved83
    P-0269041%S02ME-01improved73
    P-0227739%S05AD-05improved92
    P-0241539%S17GI-04improved86
    P-0245039%S12NP-02improved92
    P-0244138%S11SC-12improved67
    P-0246437%S18ME-01improved68
    P-0248637%S10ME-01improved86
    P-0262037%S01HY-01improved64